References
- Acmaz G, Aksoy H, Unal D, et al (2014). Are neutrophil/lymphocyte and platelet /lymphocyte ratios associated with endometrialprecancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev, 15, 1689-92. https://doi.org/10.7314/APJCP.2014.15.4.1689
- Dirican A, Kucukzeybek Y, Erten C, et al (2013). Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha. Asian Pac J Cancer Prev, 14, 2101-5. https://doi.org/10.7314/APJCP.2013.14.3.2101
- Duffy BK, Gurm HS, Rajagopal V, et al (2006). Usefulness of an elevated neutrophil to lymphocyte ratio in predicting longterm mortality after percutaneous coronary intervention. Am J Cardiol, 97, 993-6. https://doi.org/10.1016/j.amjcard.2005.10.034
- Gabrilovich DI, Nagaraj S (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 9, 162-74. https://doi.org/10.1038/nri2506
- Goldstein DP, Berkowitz RS (2012. Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am, 26, 111-31. https://doi.org/10.1016/j.hoc.2011.10.007
- Halazun KJ, Hardy MA, Rana AA, et al (2009) Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg, 250, 141-51. https://doi.org/10.1097/SLA.0b013e3181a77e59
- Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N Engl J Med, 348, 138-50. https://doi.org/10.1056/NEJMra021333
- Karaman H, Karaman A, Erden A, et al (2013). Relationship between colonic polyp type and the neutrophil/ lymphocyte ratio as a biomarker. Asian Pac J Cancer Prev, 14, 3159-61. https://doi.org/10.7314/APJCP.2013.14.5.3159
- Koh YW, Kang HJ, Park C, et al (2012). Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count inclassic Hodgkin lymphoma. Am J Clin Pathol, 138, 846-54. https://doi.org/10.1309/AJCPO46GFKGNXCBR
- Kuang DM, Zhao Q, Wu Y, et al (2011). Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol, 54, 948-55. https://doi.org/10.1016/j.jhep.2010.08.041
- Manopunya M, Suprasert P (2012). Resistant gestational trophoblastic neoplasia patients treated with 5-fluouracil plus actinomycin D. Asian Pac J Cancer Prev, 13, 387-90 https://doi.org/10.7314/APJCP.2012.13.1.387
- Movahedi K, Guilliams M, Van den Bossche J, et al (2008). Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cellsuppressive activity. Blood, 111, 4233-44. https://doi.org/10.1182/blood-2007-07-099226
- Oranratanaphan S, Lertkhachonsuk R (2014). Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn memorial hospital. Asian Pac J Cancer Prev, 15, 925-8 https://doi.org/10.7314/APJCP.2014.15.2.925
- Prabha B, Molykutty J, Swapna A, et al (2001). Increased expression of interleukin-1 beta is associated with persistence of the disease and invasion in complete hydatidiform moles. Eur J Gynaecol Oncol, 22, 50-6.
- Scapini P, Morini M, Tecchio C, et al (2004). CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol, 172, 5034-40. https://doi.org/10.4049/jimmunol.172.8.5034
- Shanbhogue AK, Lalwani N, Menias CO (2013). Gestational trophoblastic disease. Radiol Clin North Am, 51, 1023-34. https://doi.org/10.1016/j.rcl.2013.07.011
- Shi ZH, Zhao C, Wu H, et al (2011). CLIC1 protein: a candidate prognostic biomarker for malignant-transformed hydatidiform moles. Int J Gynecol Cancer, 21,153-60. https://doi.org/10.1097/IGC.0b013e3182022997
-
Shu H, Chen H, Yang B, et al (2013). Aberrant expression of E-cadherin and integrin
$\beta$ -1 in trophoblasts is associated with malignant gestational trophoblastic diseases. Int J Gynecol Cancer, 23, 749-54. https://doi.org/10.1097/IGC.0b013e31827da23f - Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. https://doi.org/10.7314/APJCP.2013.14.9.5237
- Wu Y, Zhao Q, Peng C, et al (2011). Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol, 225, 438-47. https://doi.org/10.1002/path.2947
- Yoon NB, Son C, Um SJ (2013). Role of the neutrophillymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med, 33, 105-10. https://doi.org/10.3343/alm.2013.33.2.105
- Yucel B, Babacan NA, Kacan T, et al (2013). Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev, 14, 6687-92. https://doi.org/10.7314/APJCP.2013.14.11.6687
- Zhang Z, Xu Q, Shi C, et al (2012). Interleukin-12 inhibits cell invasion in choriocarcinoma. Int J Mol Med, 30, 57-62.
Cited by
- Roles of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in the Early Diagnosis of Malignant Ovarian Masses vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6881
- Malignancy Risk Scoring of Hydatidiform Moles vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2441
- May the Neutrophil/Lymphocyte Ratio Be a Predictor in the Differentiation of Different Thyroid Disorders? vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3875
- Can Plateletcrit be a Marker for Recurrent Pregnancy Loss? vol.22, pp.5, 2016, https://doi.org/10.1177/1076029614565882
- Predictive value of some hematological parameters for non-invasive and invasive mole pregnancies vol.31, pp.3, 2018, https://doi.org/10.1080/14767058.2017.1281906